REACTINE EYE DROPS DIN 02237000
Status: Cancelled Pre Market
Holder: MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Molecule: PHENIRAMINE MALEATE
Health Canada record
| Active ingredient(s) | PHENIRAMINE MALEATE 0.3 %; NAPHAZOLINE HYDROCHLORIDE 0.025 % |
|---|---|
| Dosage form | Drops |
| Route | Ophthalmic |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | S01GA51 NAPHAZOLINE, COMBINATIONS |
| Original market date | |
| Current status date | 27-Jan-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
McNeil Consumer & Specialty Pharmaceuticals — licence , not currently licensed, last inspection rating C (2018-06-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PHENIRAMINE MALEATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02242764 | VISINE FOR ALLERGY WITH ANTIHISTAMINE | JOHNSON & JOHNSON INC | Drops | PHENIRAMINE MALEATE 0.3 %; NAPHAZOLINE HYDROCHLORIDE 0.025 % | Marketed |
| 02026511 | DIOROUGE LIQ | PHARMA STULLN INC. | Solution | PHENIRAMINE MALEATE 0.5 %; PHENYLEPHRINE HYDROCHLORIDE 0.125 %; POLYVINYL ALCOHOL 1.4 % | Dormant |
| 02241424 | HOT LEMON COUGH AND COLDS RELIEF DM | JAMP PHARMA CORPORATION | Powder For Solution | PHENIRAMINE MALEATE 20 MG; PHENYLEPHRINE HYDROCHLORIDE 10 MG; DEXTROMETHORPHAN HYDROBROMIDE 30 MG | Dormant |
| 01905376 | NEO CITRAN A POWDER | NOVARTIS CONSUMER HEALTH CANADA INC. | Powder | PHENIRAMINE MALEATE 20 MG; PHENYLEPHRINE HYDROCHLORIDE 10 MG; ASCORBIC ACID 50 MG | Cancelled Post Market |
| 01906712 | NEO CITRAN EXTRA STRENGTH | SANDOZ CANADA INC | Powder For Solution | PHENIRAMINE MALEATE 20 MG; PHENYLEPHRINE HYDROCHLORIDE 10 MG; ACETAMINOPHEN 500 MG | Cancelled Post Market |
| 01906720 | NEO CITRAN NUTRASWEET | NOVARTIS CONSUMER HEALTH CANADA INC. | Powder For Solution | PHENIRAMINE MALEATE 20 MG; PHENYLEPHRINE HYDROCHLORIDE 10 MG; ACETAMINOPHEN 325 MG | Cancelled Post Market |
| 01905368 | NEO CITRAN POWDER | NOVARTIS CONSUMER HEALTH CANADA INC. | Powder | PHENIRAMINE MALEATE 20 MG; PHENYLEPHRINE HYDROCHLORIDE 10 MG; ACETAMINOPHEN 325 MG; ASCORBIC ACID 50 MG | Cancelled Post Market |
| 00626643 | ODAN-VERNACON | ODAN LABORATORIESLTD | Solution | PHENIRAMINE MALEATE 0.5 %; PHENYLEPHRINE HYDROCHLORIDE 0.125 % | Dormant |
| 01934740 | ROBITUSSIN AC | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | Syrup | PHENIRAMINE MALEATE 7.5 MG; GUAIFENESIN 100 MG; CODEINE PHOSPHATE 10 MG | Cancelled Post Market |
| 01934732 | ROBITUSSIN SYRUP WITH CODEINE | WYETH CONSUMER HEALTHCARE INC. | Syrup | PHENIRAMINE MALEATE 7.5 MG; GUAIFENESIN 100 MG; CODEINE PHOSPHATE 3.3 MG | Cancelled Post Market |
International API supply for PHENIRAMINE MALEATE
1 valid EDQM Certificates of Suitability from 1 holders. 14 active FDA Drug Master Files.
Request a quote for REACTINE EYE DROPS